Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Sep 1, 2015 06:05 PM ET

 Add to portfolio

$242.72 USD

-5.63 (-2.27%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Jul 31, 2015

Total Return %* Percentile Rank Objective
YTD 29.02 2
3 months 17.69 1
6 months 21.04 3
1 Year 63.71 3
3 Year 44.22 1
5 Year 39.60 1
10 Year 19.02 2

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 39.96
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 7/31/2015 16,381.65
%Turnover 7/31/2015 61.00

Risk

3 Year 5 Year 10 Year
Beta 0.91 0.90 0.78
Alpha 27.06 23.85 13.03
R Squared 0.13 0.28 0.33
Std. Dev. 21.50 19.96 20.07
Sharpe 2.20 2.11 2.00

Sector / Country Weightings

As of 7/31/2015 % of Portfolio
Health 65.57
Services 19.97
Other 13.26
Industrial Cyclical 0.95
Technology 0.21
Finance 0.04

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2015)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.89 1,237.77
BIOGEN INC 6.96 1,091.81
CELGENE CORP 4.83 758.50
VERTEX PHARMACEUTICALS IN 4.08 640.91
REGENERON PHARMACEUTICALS 3.74 587.22
ALEXION PHARMACEUTICALS I 3.57 560.68
BIOMARIN PHARMACEUTICAL 3.35 526.59
MEDIVATION INC 2.41 378.34
INCYTE PHARMACEUTICALS IN 2.20 345.57

Stock Holding % of Net Assets

As Of 5/31/2015
Total Issues 207
Avg. P/E 40.12
Avg. P/Book 5.97
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 30,541

Allocation

% of Portfolio
Large Growth 11.51
Large Value 0.00
Small Growth 51.26
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00